ALS patient-derived neuron networks showed dysfunction and increased centralisation
Original source
Microscale dysfunction and mesoscale compensation in degenerating neuronal networks. (opens in a new tab)Compass summarised this from the study's abstract.
Study details
- Studied in
- Human
Population inferred from the title and abstract by Compass.
ALS patient-derived motor neuron networks developed abnormal activity and structural changes compared with healthy-control networks in a laboratory study. Over time, the networks became more centralised, with greater reliance on highly connected hub nodes, which the researchers interpreted as compensation that may eventually strain those nodes.
Why this matters
The findings offer a laboratory model for studying how ALS-related network changes develop before or during degeneration. They do not show a treatment benefit or change care for people with ALS, because the work was conducted in engineered cell networks rather than in patients.
Limitations and context
This was preclinical research using in vitro, patient-derived neuron networks and longitudinal multielectrode recordings. The supplied source does not provide the sample size or clinical details of the donors, and these findings still need to be tested in living organisms and people with ALS. The source is a primary journal article, not evidence of a clinical intervention.